@ARTICLE{
author={Tiede Andreas,Janic Dragana M,Ozelo M,Santagostino E,Korsholm Lars,Matytsina Irina,Lentz SR},
year={2018},
title={Use of turoctocog alfa for less-frequent prophylaxis in selected patients has comparable efficacy with the overall prophylaxis cohort in Guardian (TM) 2},
journal={HAEMOPHILIA},
volume={24},
number={},
pages={52-52},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Santagostino E,Martin Salces M,Lejniece Sandra,Janic Dragana M,Tripkovic N,Matytsina Irina},
year={2017},
title={Spontaneous Bleeding Rate On Turoctocog Alfa Prophylaxis in a Large Cohort of Patients With Haemophilia A Followed For up to 5 Years - Trends Over Time and Across Geography},
journal={HAEMOPHILIA},
volume={23},
number={},
pages={56-57},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Lentz SR,Cerqueira MH,Janic Dragana M,Kempton CL,Matytsina Irina,Misgav M,Oldenburg J,Ozelo M,Recht M,Rosholm A,Savic Aleksandar D,Suzuki Takashi,Tiede Andreas,Santagostino E},
year={2016},
title={Interim results from a large multinational extension trial (guardian (TM) 2) using turoctocog alfa for prophylaxis and treatment of bleeding in patients with severe haemophilia A},
journal={HAEMOPHILIA},
volume={22},
number={5},
pages={E445-E449},
document_type={Letter},
} 

@ARTICLE{
author={Lentz SR,Kempton CL,Janic Dragana M,Savic Aleksandar D,Cerqueira MH,Ozelo MC,Recht M,Oldenburg J,Tiede Andreas,Suzuki Takashi,Matytsina Irina,Zeuthen N,Santagostino E},
year={2015},
title={Interim results from a large multinational extension trial (Guardian TM2) using turoctocog alfa for prophylaxis and treatment of bleeding in patients with severe haemophilia A},
journal={JOURNAL OF THROMBOSIS AND HAEMOSTASIS},
volume={13},
number={},
pages={842-842},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Matytsina Irina,Janic Dragana M,Lejniece Sandra,Santagostino E},
year={2015},
title={Safety of Turoctocog Alfa for The Prevention and Treatment of Bleeds in Patients with Haemophilia A: Results for The Guardian (TM) Clinical Trials},
journal={HAEMOPHILIA},
volume={21},
number={},
pages={33-33},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Santagostino E,Lentz SR,Misgav M,Brand B,Chowdary Pratima,Savic Aleksandar D,Kilinc Yurdanur,Amit Y,Amendola A,Solimeno LP,Saugstrup T,Matytsina Irina},
year={2015},
title={Safety and efficacy of turoctocog alfa (NovoEight (R)) during surgery in patients with haemophilia A: results from the multinational guardian (TM) clinical trials},
journal={HAEMOPHILIA},
volume={21},
number={1},
pages={34-40},
document_type={Article},
} 

@ARTICLE{
author={Kulkarni R,Karim Abdul F,Glamocanin S,Janic Dragana M,Vdovin V,Ozelo M,Rageliene L,Carboni E,Laguna P,Dobaczewski G,Seremetis S,Lindblom A,Santagostino E},
year={2013},
title={Results from a large multinational clinical trial (guardian (TM) 3) using prophylactic treatment with turoctocog alfa in paediatric patients with severe haemophilia A: safety, efficacy and pharmacokinetics},
journal={HAEMOPHILIA},
volume={19},
number={5},
pages={698-705},
document_type={Article},
} 

@ARTICLE{
author={Kulkarni R,Karim Abdul F,Glamocanin S,Janic Dragana M,Vdovin V,Ozelo M,Rageliene L,Carboni E,Laguna P,Dobaczewski G,Santagostino E},
year={2012},
title={Safety and efficacy of turoctocog alfa in the prevention and treatment of bleeding episodes in paediatric patients with severe haemophilia A and below 12 years of age},
journal={HAEMOPHILIA},
volume={18},
number={5},
pages={829-829},
document_type={Meeting Abstract},
}